Literature DB >> 12818175

CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein.

Annette Schenck1, Barbara Bardoni, Caillin Langmann, Nicholas Harden, Jean Louis Mandel, Angela Giangrande.   

Abstract

Neuronal plasticity requires actin cytoskeleton remodeling and local protein translation in response to extracellular signals. Rho GTPase pathways control actin reorganization, while the fragile X mental retardation protein (FMRP) regulates the synthesis of specific proteins. Mutations affecting either pathway produce neuronal connectivity defects in model organisms and mental retardation in humans. We show that CYFIP, the fly ortholog of vertebrate FMRP interactors CYFIP1 and CYFIP2, is specifically expressed in the nervous system. CYFIP mutations affect axons and synapses, much like mutations in dFMR1 (the Drosophila FMR1 ortholog) and in Rho GTPase dRac1. CYFIP interacts biochemically and genetically with dFMR1 and dRac1. Finally, CYFIP acts as a dRac1 effector that antagonizes FMR1 function, providing a bridge between signal-dependent cytoskeleton remodeling and translation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818175     DOI: 10.1016/s0896-6273(03)00354-4

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  125 in total

1.  nev (cyfip2) is required for retinal lamination and axon guidance in the zebrafish retinotectal system.

Authors:  Andrew J Pittman; John A Gaynes; Chi-Bin Chien
Journal:  Dev Biol       Date:  2010-06-09       Impact factor: 3.582

2.  Deciphering the elusive nature of sharp bone trauma using epifluorescence macroscopy: a comparison study multiplexing classical imaging approaches.

Authors:  Caroline Capuani; Jacques Rouquette; Bruno Payré; Jacques Moscovici; Marie Bernadette Delisle; Norbert Telmon; Céline Guilbeau-Frugier
Journal:  Int J Legal Med       Date:  2012-02-23       Impact factor: 2.686

3.  Fragile X protein controls neural stem cell proliferation in the Drosophila brain.

Authors:  Matthew A Callan; Clemens Cabernard; Jennifer Heck; Samantha Luois; Chris Q Doe; Daniela C Zarnescu
Journal:  Hum Mol Genet       Date:  2010-05-26       Impact factor: 6.150

4.  Molecular and genetic analysis of the Drosophila model of fragile X syndrome.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Results Probl Cell Differ       Date:  2012

Review 5.  A fruitfly's guide to keeping the brain wired.

Authors:  Maarten Leyssen; Bassem A Hassan
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

Review 6.  Rho-linked genes and neurological disorders.

Authors:  Nael Nadif Kasri; Linda Van Aelst
Journal:  Pflugers Arch       Date:  2007-11-15       Impact factor: 3.657

7.  ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory.

Authors:  Matthew Grove; Galina Demyanenko; Asier Echarri; Patricia A Zipfel; Marisol E Quiroz; Ramona M Rodriguiz; Martin Playford; Shelby A Martensen; Matthew R Robinson; William C Wetsel; Patricia F Maness; Ann Marie Pendergast
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A convergently regulate the synaptic ratio of ionotropic glutamate receptor subclasses.

Authors:  Luyuan Pan; Kendal S Broadie
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

9.  Testing candidate genes for attention-deficit/hyperactivity disorder in fruit flies using a high throughput assay for complex behavior.

Authors:  Palle Duun Rohde; Lisbeth Strøm Madsen; Sandra Marie Neumann Arvidson; Volker Loeschcke; Ditte Demontis; Torsten Nygaard Kristensen
Journal:  Fly (Austin)       Date:  2016-03-08       Impact factor: 2.160

10.  A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype.

Authors:  Andrew J Syder; Sherif M Karam; Jason C Mills; Joseph E Ippolito; Habib R Ansari; Vidya Farook; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.